Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
MERIDIAN BIOSCIENCE INC (VIVO) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/28/2021 GN Meridian Simplifies Workflows for POC Molecular Tests with a New Lyo-Ready™ LAMP Mix
04/19/2021 GN Meridian Bioscience to Hold Second Quarter Fiscal 2021 Financial Results Conference Call on May 7, 2021
04/01/2021 GN Meridian Bioscience Announces FDA Submission for New Curian® Campy Assay
03/08/2021 GN Meridian Launches its New Air-Dryable Mix for Crude Blood Samples
02/23/2021 GN Meridian Bioscience Corrects Prior Update Regarding Revogene® SARS-CoV-2 EUA Withdrawal
02/23/2021 GN Meridian Bioscience Provides a Further Update on the Revogene® SARS-CoV-2 EUA Submission
02/16/2021 GN Meridian Bioscience Provides an Update on the Revogene® SARS-CoV-2 EUA Submission
02/05/2021 GN Meridian Bioscience Reports Record Setting First Quarter Fiscal 2021 Operating Results and Raises Full Year Fiscal 2021 Guidance
02/03/2021 GN Meridian Bioscience Expands Production Capacity with Support from NIH, JobsOhio, and the Village of Newtown
02/02/2021 GN Meridian's Air-Dryable Master Mixes Replace Lyophilization in the Manufacturing of Molecular Assays
01/06/2021 GN Meridian Bioscience to Participate in H. C. Wainright Bioconnect 2021 Virtual Conference
12/16/2020 GN Meridian Bioscience receives NIH Award for supporting rapid development of Revogene® molecular test for SARS-CoV-2
12/08/2020 GN Meridian Bioscience submits application to FDA for Emergency Use Authorization for SARS-CoV-2 molecular assay
12/03/2020 GN Meridian Launches its Novel Air-Dryable RT-qPCR Mix, Further Decreases Costs and Simplifies Workflows for COVID-19 Molecular Test Manufacturers
11/23/2020 GN Meridian Bioscience Participates in Piper Sandler 32nd Annual Virtual Healthcare Conference
11/13/2020 GN Meridian Bioscience Reports Strong Fourth Quarter and Record Full-Year Fiscal 2020 Operating Results and Provides Fiscal 2021 Guidance
10/20/2020 GN Meridian Bioscience to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call on November 13, 2020
10/07/2020 GN Meridian Bioscience Launches a Complete Solution to Support Liquid Biopsy Cancer Diagnostics
10/06/2020 GN VIVO Cannabis™ Announces Fully Marketed $5 Million Public Offering
09/14/2020 GN Meridian launches a novel SARS-CoV-2 antibody pair designed for developing highly sensitive rapid antigen tests from saliva samples
07/28/2020 GN Meridian Bioscience Announces New Board Member - Anthony Bihl
07/16/2020 GN Meridian Bioscience to Hold Third Quarter 2020 Financial Results Conference Call on August 7, 2020
05/26/2020 GN Meridian Bioscience Announces It Will Supply Reagents for the Manufacturing of Tens of Millions of COVID-19 Antibody Tests Per Month
05/20/2020 GN Meridian Bioscience Promotes Tony Serafini-Lamanna to Executive Vice President of Diagnostics
05/08/2020 GN Meridian Bioscience Reports Second Quarter 2020 Operating Results; Raises Guidance on Strength of COVID-19 Related Products
04/30/2020 GN Meridian Bioscience Announces Closing of Transaction to Acquire Exalenz Bioscience
04/27/2020 GN Meridian Bioscience Simplifies COVID-19 Sample Prep and Eliminates Dependence on Reagents in Short Supply
04/16/2020 GN Meridian Bioscience To Hold Second Quarter 2020 Financial Results Conference Call On May 8, 2020
04/14/2020 GN Meridian Bioscience offers SARS-CoV-2 antigens for COVID-19 Antibody Tests
04/02/2020 GN MERIDIAN BIOSCIENCE ANNOUNCES BETTER-THAN-EXPECTED PRELIMINARY SECOND QUARTER FISCAL 2020 REVENUE RESULTS WITH DOUBLE-DIGIT GROWTH
03/16/2020 GN Meridian Bioscience Supports Diagnostic Companies in Fighting Coronavirus Pandemic by Providing Zero Cost Proprietary Technology for Evaluation
02/19/2020 GN Meridian Bioscience Signs Definitive Agreement to Acquire Exalenz Bioscience; Adds State-Of-The-Art Urea Breath Test Diagnostics Platform
01/27/2020 GN Meridian Bioscience Lyo-Ready 1-Step RT-qPCR Mix is Used in the Development of Molecular Diagnostics for New Coronavirus Outbreak
01/15/2020 GN Meridian Bioscience to Hold First Quarter 2020 Financial Results Conference Call on February 7, 2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy